SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 118.66   -0.11 (-0.09%) Volume: 82.78k 12:56 PM EDT 16-Jul-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans707/29/1997
10-QGeneral form for quarterly reports under Section 13 or 15(d)305/15/1997
DEF 14AOther definitive proxy statements104/21/1997
SC 13DGeneral statement of acquisition of beneficial ownership104/15/1997
10-KAnnual report pursuant to Section 13 or 15(d)1103/31/1997
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/13/1997
10-QGeneral form for quarterly reports under Section 13 or 15(d)311/14/1996
424B1Prospectus [Rule 424(b)(1)]110/25/1996
S-3/A[Amend] Registration statement under Securities Act of 1933410/22/1996
8-A12GRegistration of securities [Section 12(g)]209/30/1996
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans709/27/1996
S-3Registration statement under Securities Act of 1933309/25/1996
10-QGeneral form for quarterly reports under Section 13 or 15(d)608/14/1996
10-QGeneral form for quarterly reports under Section 13 or 15(d)205/09/1996
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/06/1996
102103104105106107108109110111112113114115116